Brian D Evavold

16PUBLICATIONS
82CO-AUTHORS
Tissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCellular immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 19, 2026
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering.

Xiaojing Chen, Zhiyuan Mao, E Motunrayo Kolawole

|Feb 06, 2024
Cbl-b mitigates the responsiveness of naive CD8+ T cells that experience extensive tonic T cell receptor signaling.

Joel Eggert, Wendy M Zinzow-Kramer, Yuesong Hu

|Jul 17, 2023
What's the Catch? The Significance of Catch Bonds in T Cell Activation.

Michael A Faust, Viva J Rasé, Tracey J Lamb

|Jul 17, 2023
Force in Immunology: There Is Often a Catch.

Brian D Evavold

|Mar 08, 2023
Immunogen-Specific Strengths and Limitations of the Activation-Induced Marker Assay for Assessing Murine Antigen-Specific CD4+ T Cell Responses.

Nguyen X Nguyen, Andrew W Richens, Linda M Sircy

Pageof 3